Communicable Disease Control Handbook 2e

Dr Jeremy Hawker, Deputy Director, Local and Regional Services, Health Protection Agency, UK Dr Norman Begg, Director of Medical Affairs, GlaxoSmithKline, Uxbridge, UK Dr Iain Blair, Consultant in Communicable Disease, Health Protection Agency, Hampshire, UK Professor Ralf Reintjes, Professor for Epidemiology and Public Health Surveillance, Hamburg University of Applied Science, Germany Professor Julius Weinberg, Pro-Vice Chancellor, City University, London, UK

Section 1: Introduction. 1.1 How to use this book. 1.2 Basic concepts in epidemiology and control of infection. 1.3 Health Protection on-call. Section 2: Common Topics. 2.1 Meningitis and meningism. 2.2 Gastrointestinal infection. 2.3 Community acquired pneumonia. 2.4 Rash in pregnancy. 2.5 Rash and fever in children. 2.6 Illness in returning travellers. 2.7 Sexually transmitted infections. 2.8 Jaundice. 2.9 Infection in the immunocompromised. 2.10 Blood-borne viral infection. 2.11 Vaccine queries. Section 3: Diseases. 3.1 Amoebic dysentery. 3.2 Anthrax. 3.3 Bacillus cereus. 3.4 Botulism. 3.5 Brucellosis. 3.6 Campylobacter. 3.7 Chickenpox and shingles (varicella-zoster infections). 3.8 Chlamydia pneumoniae. 3.9 Chlamydia psittaci. 3.10 Chlamydia trachomatis (genital). 3.11 Cholera. 3.12 CJD and other Human Transmissable Spongiform Encephalopathies. 3.13 Clostridium difficile. 3.14 Clostridium perfringens. 3.15 Coxsackievirus infections. 3.16 Cryptosporidiosis. 3.17 Cyclosporiasis. 3.18 Cytomegalovirus. 3.19 Dengue fever. 3.20 Diphtheria. 3.21 Encephalitis, acute. 3.22 Enterococci, including Glycopeptide-resistant enterococci (GRE). 3.23 Epstein-Barr virus. 3.24 Escherischia coli O157 (and other E. coli gastroenteritis). 3.25 Giardiasis. 3.26 Gonorrhoea, syphilis and other acute STIs. 3.27 Hantavirus. 3.28 Headlice. 3.29 Helicobacter pylori. 3.30 Hepatitis A. 3.31 Hepatitis B. 3.32 Hepatitis C. 3.33 Delta Hepatitis. 3.34 Hepatitis E. 3.35 Herpes simplex. 3.36 Haemophilus influenzae type b (Hib) infection. 3.37 HIV. 3.38 Influenza. 3.39 Japanese B encephalitis. 3.40 Kawasaki Syndrome. 3.41 Legionellosis. 3.42 Leprosy. 3.43 Leptospirosis. 3.44 Listeria. 3.45 Lyme disease. 3.46 Malaria. 3.47 Measles. 3.48 Meningococcal infection. 3.49 Molluscum contagiosum. 3.50 MRSA (methicillin-restisant Staphylococcus aureus). 3.51 Mumps. 3.52 Mycoplasma. 3.53 Norovius. 3.54 Ophthalmia neonatorum. 3.55 Paratyphoid fever. 3.56 Parvovirus B19 (fifth disease). 3.57 Plague. 3.58 Pneumococcal infection. 3.59 Poliomyelitis. 3.60 Q fever. 3.61 Rabies. 3.62 Relapsing fever. 3.63 Respiratory syncytial virus (RSV). 3.64 Ringworm. 3.65 Rotavirus. 3.66 Rubella. 3.67 Salmonellosis. 3.68 Severe Acute Respiratory Syndrome (SARS). 3.69 Scabies. 3.70 Shigella . 3.71 Smallpox. 3.72 Staphylococcal food poisoning. 3.73 Streptococcal infections. 3.74 Tetanus. 3.75 Threadworms. 3.76 Tick-borne encephalitis. 3.77 Toxocara. 3.78 Toxoplasmosis. 3.79 Tuberculosis. 3.80Tularaemia. 3.81 Typhoid fever. 3.82 Typhus, other rickettsial infections and Ehrlichiosis. 3.83 Vibrio parahaemolyticus. 3.84 Viral haemorrhagic fevers. 3.85 Warts & verrucae. 3.86 West Nile virus. 3.87 Whooping cough(pertussis). 3.88 Yellow fever. 3.89 Yersiniosis. 3.90 Other organisms. 1. Helminths. 2. Protozoa. 3. Fungi. 4. Viruses. 5. Bites, stings and venoms. 6. Chemical food-borne illness. Section 4: Services and Organisations. 4.1 Administrative arrangements for communicable disease control. 4.2 Surveillance of communicable disease. 4.3 Managing infectious disease incidents and outbreaks. 4.4 Community infection control. 4.5 Healthcare associated infection. 4.6 Risks to & from healthcare workers. 4.7 Co-ordination of immunisation services. 4.8 Co-ordination of services for HIV infection in the UK. 4.9 Co-ordination of services for tuberculosis control. 4.10 Travel Health and Illness in returning travellers. 4.11 Surveillance & investigation of environmental hazards. 4.12 Managing acute chemical incidents. 4.13 Managing acute radiation incidents. 4.14 Planning for deliberate release of biological, chemical or radiological agents. 4.15 Port health. 4.16 Media relations. 4.17 Clinical governance and audit. Section 5: Communicable Disease Control in Europe. 5.1 International collaboration in Europe. 5.2 Austria. 5.3 Belgium. 5.4 Cyprus. 5.5 Czech Republic. 5.6 Denmark. 5.7 Estonia. 5.8 France. 5.9 Finland. 5.10 Germany. 5.11 Greece. 5.12 Hungary. 5.13 Republic of Ireland. 5.14 Italy. 5.15 Latvia. 5.16 Lithuania. 5.17 Luxemburg. 5.18 Malta. 5.19 Netherlands. 5.20 Norway. 5.21 Poland. 5.22 Portugal. 5.23 Slovakia. 5.24 Slovenia. 5.25 Spain. 5.26 Sweden. 5.27 Switzerland. 5.28 United Kingdom. Appendix 1: Useful addresses telephone numbers. Appendix 2: Guidance documents and books